2020
DOI: 10.31080/asor.2020.03.0232
|View full text |Cite
|
Sign up to set email alerts
|

Aceclofenac in Osteoarthritis - NSAID with Novel Mechanism of Action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…ACF has a strong anti-inflammatory and analgesic action. Its stronger inhibition selectivity on COX 2 than COX 1 explains its safety in comparison to other NSAIDs and COX 2 selective inhibitors, as well as its improved stomach tolerance and fewer side effects (5) . ACF is weakly acidic drug with pka about 4.7 and belongs to BCS class II and it's practically insoluble in water (about 0.007 mg/mL) with high permeability and poor dissolution rate that leads to reduced oral bioavailability.…”
Section: Introductionmentioning
confidence: 99%
“…ACF has a strong anti-inflammatory and analgesic action. Its stronger inhibition selectivity on COX 2 than COX 1 explains its safety in comparison to other NSAIDs and COX 2 selective inhibitors, as well as its improved stomach tolerance and fewer side effects (5) . ACF is weakly acidic drug with pka about 4.7 and belongs to BCS class II and it's practically insoluble in water (about 0.007 mg/mL) with high permeability and poor dissolution rate that leads to reduced oral bioavailability.…”
Section: Introductionmentioning
confidence: 99%